SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

_________________

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act Of 1934

Date of report (date of earliest event reported): March 4, 2004

  ALARIS MEDICAL SYSTEMS, INC.  

(Exact name of registrant as specified in its charter)

Delaware 1-10207 13-3492624

(State or other jurisdiction of (Commission File Number) (I.R.S. Employer
incorporation or organization)   Identification Number)
 

  10221 Wateridge Circle
San Diego, CA 92121-1579
 

(Address, including zip code, of registrant’s principal executive offices)
 

  (858) 458-7000  

Registrant’s telephone number, including area code





Item 12. Results of Operations and Financial Condition

  The following information is being furnished under Item 12, Results of Operations and Financial Condition. Such information, including the Exhibit attached hereto, shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934:

  On March 4, 2004, ALARIS Medical Systems, Inc. issued the press release attached as Exhibit 99.1, reporting its results for the year ended December 31, 2003.

SIGNATURES

  Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

     
     
    ALARIS MEDICAL SYSTEMS, INC.


          Date: March 4, 2004 By: /s/ DAVID L. SCHLOTTERBECK
————————————————
David L. Schlotterbeck
President and Chief Executive Officer



EXHIBIT INDEX

       Exhibit

99.1 Press release of ALARIS Medical Systems, Inc., dated March 4, 2004, reporting results for the year ended December 31, 2003.